Selective cyclooxygenase-2-(COX-2) inhibitor. Belief, reality and hope;Selektive Zyklooxygenase-2(cox-2)-Hemmer. Glaube, Realitat und Hoffnung. Mit Fazit fur die Praxis und Kommentar von B. Nurnberg und U. Weber

Orthopade

Volumn 26, Issue 9, 1997, Pages 804-807

  Brune, K ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; CYCLOOXYGENASE 2 INHIBITOR; DUP 687; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; KETOROLAC; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NIMESULIDE; PIROXICAM; TENOXICAM; UNCLASSIFIED DRUG;

DRUG EFFECT; DRUG RESEARCH; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; REVIEW;

ACUTE-PHASE REACTION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0030853608     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001320050159     Document Type: Review

References (13)

1. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M (1996) Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 390: 165-169
2. DeWitt D, Smith WL (1995) Yes, but do they still get headaches? Cell 83: 345-348
3. Garavito RM (1996) The cyclooxygenase-2 structure: new drugs for an old target? Nature Struct Biol 3: 897-901
4. Gierse JK, Hauser SD, Creely DR Koboldt C, Rangwala SH, Isakson PC, Seibert K (1995) Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 305:479-484
5. Griswold DE, Adams JL (1996) Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 16:181-206
6. Levy GN (1997) Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer. FASEB J 11: 234-247
7. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci (USA) 90: 11693-11697
8. Panara MR, Greco A, Santini G, Sciulli MG, Rotondo MT, Padovano R, Di Giamberardino M, Cipollone F, Cucurullo F, Patrono C, Patrignani P (1995) Effect of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745-337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxydase. Br J Pharmacol 116, 2429-2434
9. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Crèminon C, Maclouf J, Patrono C (1994) Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxidase synthase. J Pharmacol Exp Ther 271:1705-1712
10. Polisson R (1996) Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection. Am J Med 100 [Suppl 2A]-13S-36S
11. Service RF (1996) Closing in on a stomach-sparing aspirin substitute. Science 273: 1660
12. Vane J (1994) Towards a better aspirin. Nature (London) 367: 215-216
13. Williams CS, DuBois RN (1996) Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270, G393-G400